PrimeVax Immuno-Oncology
www.primevax.comPrimeVax Immuno-Oncology, Inc. is developing the only one-time, one-week cancer treatment. We use a combination of the dengue fever virus and autologous dendritic cells to induce a strong immune response along with personalized tumor targeting.
Read more
PrimeVax Immuno-Oncology, Inc. is developing the only one-time, one-week cancer treatment. We use a combination of the dengue fever virus and autologous dendritic cells to induce a strong immune response along with personalized tumor targeting.
Read more
Country
State
California
City (Headquarters)
South San Francisco
Industry
Employees
1-10
Founded
2015
Social
Employees statistics
View all employeesPotential Decision Makers
Interim Chief Executive Officer
Email ****** @****.comPhone (***) ****-****Board of Directors
Email ****** @****.comPhone (***) ****-****Senior Director of Translational Science
Email ****** @****.comPhone (***) ****-****Information Technology Analyst
Email ****** @****.comPhone (***) ****-****
Technologies
(7)
Reach decision makers at PrimeVax Immuno-Oncology
Free credits every month!
PrimeVax Immuno-Oncology FAQ
South San Francisco, United States
Biotechnology Research
